These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12422060)

  • 1. Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.
    Sato K; Yoshida K; Takahashi H; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
    Neuropsychobiology; 2002; 46(3):136-40. PubMed ID: 12422060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
    Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
    Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.
    Takahashi H; Yoshida K; Higuchi H; Kamata M; Inoue K; Suzuki T; Ishigooka J
    Neuropsychobiology; 2014; 70(3):173-80. PubMed ID: 25358426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine.
    Yoshida K; Naito S; Takahashi H; Sato K; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Suzuki T; Ohkubo T
    Neuropsychobiology; 2003; 48(1):10-3. PubMed ID: 12886034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of SIGMAR1 with major depressive disorder and SSRI response.
    Kishi T; Yoshimura R; Okochi T; Fukuo Y; Kitajima T; Okumura T; Tsunoka T; Kawashima K; Yamanouchi Y; Kinoshita Y; Umene-Nakano W; Naitoh H; Nakamura J; Ozaki N; Iwata N
    Neuropharmacology; 2010 Jun; 58(7):1168-73. PubMed ID: 20178807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.
    Gerstenberg G; Aoshima T; Fukasawa T; Yoshida K; Takahashi H; Higuchi H; Murata Y; Shimoyama R; Ohkubo T; Shimizu T; Otani K
    Psychopharmacology (Berl); 2003 Jun; 167(4):443-8. PubMed ID: 12682708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients.
    Saito S; Takahashi N; Ishihara R; Ikeda M; Suzuki T; Kitajima T; Yamanouchi Y; Iwata N; Yamada M; Yoshida K; Inada T; Ozaki N
    Neuropsychobiology; 2006; 54(4):226-30. PubMed ID: 17356306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients.
    Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Tsunoka T; Ozaki N; Iwata N
    Neuromolecular Med; 2009; 11(2):53-7. PubMed ID: 19347611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.
    Kato M; Wakeno M; Okugawa G; Fukuda T; Takekita Y; Hosoi Y; Azuma J; Kinoshita T; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1041-4. PubMed ID: 18325652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
    Higuchi H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
    Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
    Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients.
    Suzuki Y; Sawamura K; Someya T
    Neuropsychopharmacology; 2006 Apr; 31(4):825-31. PubMed ID: 16205777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
    Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
    Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.
    Kato M; Fukuda T; Wakeno M; Fukuda K; Okugawa G; Ikenaga Y; Yamashita M; Takekita Y; Nobuhara K; Azuma J; Kinoshita T
    Neuropsychobiology; 2006; 53(4):186-95. PubMed ID: 16874005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].
    Sugie Y; Sugie H; Fukuda T; Ito M; Ohzeki T
    No To Hattatsu; 2003 Jan; 35(1):23-8. PubMed ID: 12607287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder.
    Kishi T; Ichinose H; Yoshimura R; Fukuo Y; Kitajima T; Inada T; Kunugi H; Kato T; Yoshikawa T; Ujike H; Musso GM; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
    J Affect Disord; 2012 Dec; 142(1-3):315-22. PubMed ID: 22770721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.
    Yoshida K; Ito K; Sato K; Takahashi H; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):383-6. PubMed ID: 11817517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene.
    Choi MJ; Lee HJ; Lee HJ; Ham BJ; Cha JH; Ryu SH; Lee MS
    Neuropsychobiology; 2004; 49(1):38-41. PubMed ID: 14730199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.